Filing Details
- Accession Number:
- 0001209191-18-008618
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-08 20:43:18
- Reporting Period:
- 2018-02-06
- Accepted Time:
- 2018-02-08 20:43:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | LIFE | Biological Products, (No Disgnostic Substances) (2836) | 203435077 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657162 | T John Blake | 3545 John Hopkins Court, Suite 250 San Diego CA 92121 | Senior Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-07 | 3,334 | $0.00 | 3,334 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-08 | 1,402 | $3.40 | 1,932 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2018-02-06 | 75,000 | $0.00 | 75,000 | $3.30 |
| Common Stock | Restricted Stock Units | Disposition | 2018-02-07 | 3,334 | $0.00 | 3,334 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 75,000 | 2028-02-06 | No | 4 | A | Direct | |
| 6,666 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017.
- Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 7, 2017.
- The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2018, such that this option will be fully exercisable on February 6, 2022. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the grant commencing on February 7, 2018.
Billionaire Hedge Funds
